{"id":"W2086921761","doi":"10.1158/1535-7163.targ-11-a229","title":"Abstract A229: BRAF inhibitors upregulate EGFR ligands: A molecular link to RAF inhibitor-induced cutaneous squamous cell carcinomas.","year":2011,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Workplace Health, Safety and Compensation Commission","funders":"","keywords":"Vemurafenib; Cancer research; HRAS; Melanoma; Cancer; Downregulation and upregulation; Neuroblastoma RAS viral oncogene homolog; EGFR inhibitors; MAPK/ERK pathway; Skin cancer; Kinase; Cell growth; Medicine; Biology; KRAS; Epidermal growth factor receptor; Internal medicine; Colorectal cancer; Cell biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001828575,0.0007107483,0.000481238,0.0001679825,0.0001625676,0.00007830474,0.0006721581,0.0006230409,0.0000898922],"category_scores_gemma":[0.00002098867,0.0007312769,0.0003971606,0.0003192519,0.00009822765,0.0000122308,0.0002885122,0.0003855449,0.00007796019],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001077504,"about_ca_system_score_gemma":0.0003394953,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00031443,"about_ca_topic_score_gemma":0.00009012011,"domain_scores_codex":[0.9967209,0.00008865357,0.0006328991,0.001102846,0.0004882037,0.0009665734],"domain_scores_gemma":[0.9977818,0.00001436831,0.0002401902,0.001240522,0.0002439112,0.0004792348],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003083592,0.0001868957,0.0004599111,0.00007448352,0.0001533007,0.0005205116,0.0006594866,0.0001525341,0.9817195,0.00005935262,0.0002862342,0.01541942],"study_design_scores_gemma":[0.001203367,0.0009484197,0.0009920975,0.0000461643,0.0001620633,0.00007356506,0.00007787283,0.00003674845,0.9779076,0.0001241308,0.01749735,0.0009306059],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9882796,0.004089022,0.001212588,0.000328066,0.001117608,0.000827306,0.00006076605,0.0001010609,0.003983915],"genre_scores_gemma":[0.9941236,0.0001414426,0.0007654529,0.003552494,0.0006002013,0.0001549701,0.00007601931,0.0002179405,0.0003679008],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01721112,"threshold_uncertainty_score":0.9995138,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02256382766487966,"score_gpt":0.2431232919268744,"score_spread":0.2205594642619947,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}